D
Dizlin Pharmaceuticals AB
Profile managed by Bizz IdDizlin
Suecia
1-10 employees
2003
Description
Swedish pharmaceutical company founded in 2003 specialised in advanced Parkinson's disease. Develops Infudopa SubC® (continuous subcutaneous infusion, wearable device) and Infudopa IntraV® (intravenous). Global co-development deal with Neuraxpharm signed in 2025.